Terms: = Leukemia AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Diagnosis
51 results:
1. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract] [Full Text] [Related]
2. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting Pim-3.
Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
[TBL] [Abstract] [Full Text] [Related]
3. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
[TBL] [Abstract] [Full Text] [Related]
4. Exploring underlying mechanism of artesunate in treatment of acute myeloid leukemia using network pharmacology and molecular docking.
Tao Y; Li W; Yang J; Xue T; Wang Y; Dong X; Xu H; Ren J; Lu J
Clin Transl Oncol; 2023 Aug; 25(8):2427-2437. PubMed ID: 36952106
[TBL] [Abstract] [Full Text] [Related]
5. 1,5-Anhydroglucitol promotes pre-B acute lymphocytic leukemia progression by driving glycolysis and reactive oxygen species formation.
Zhu H; Ma H; Dong N; Wu M; Li D; Liu L; Shi Q; Ju X
BMC Cancer; 2023 Feb; 23(1):122. PubMed ID: 36747147
[TBL] [Abstract] [Full Text] [Related]
6. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
Palomo M; Youssef L; Ramos A; Torramade-Moix S; Moreno-Castaño AB; Martinez-Sanchez J; Bonastre L; Pino M; Gomez-Ramirez P; Martin L; Garcia Mateos E; Sanchez P; Fernandez S; Crovetto F; Escolar G; Carreras E; Castro P; Gratacos E; Crispi F; Diaz-Ricart M
Am J Obstet Gynecol; 2022 Aug; 227(2):277.e1-277.e16. PubMed ID: 35351411
[TBL] [Abstract] [Full Text] [Related]
7. Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of
Kuzilková D; Bugarin C; Rejlova K; Schulz AR; Mei HE; Paganin M; Biffi A; Biondi A; Kalina T; Gaipa G
Haematologica; 2022 Jun; 107(6):1293-1310. PubMed ID: 34670357
[TBL] [Abstract] [Full Text] [Related]
8. p38 MAPK/AKT signalling is involved in IL-33-mediated anti-apoptosis in childhood acute lymphoblastic leukaemia blast cells.
Wang Y; Hou H; Liang Z; Chen X; Lian X; Yang J; Zhu Z; Luo H; Su H; Gong Q
Ann Med; 2021 Dec; 53(1):1461-1469. PubMed ID: 34435521
[TBL] [Abstract] [Full Text] [Related]
9. Crosstalk between hnRNP K and SET in ATRA-induced differentiation in acute promyelocytic leukemia.
Padovani KS; Goto RN; Fugio LB; Garcia CB; Alves VM; Brassesco MS; Greene LJ; Rego EM; Leopoldino AM
FEBS Open Bio; 2021 Jul; 11(7):2019-2032. PubMed ID: 34058077
[TBL] [Abstract] [Full Text] [Related]
10. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and erk signaling pathways.
Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
[TBL] [Abstract] [Full Text] [Related]
11.
Loscocco GG; Rotunno G; Mannelli L; Mannelli F; Vergoni F; Guglielmelli P; Vannucchi AM
Tumori; 2021 Dec; 107(6):NP28-NP32. PubMed ID: 33430710
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin-33 Promotes Cell Survival via p38 MAPK-Mediated Interleukin-6 Gene Expression and Release in Pediatric AML.
Wang Y; Su H; Yan M; Zhang L; Tang J; Li Q; Gu X; Gong Q
Front Immunol; 2020; 11():595053. PubMed ID: 33324412
[TBL] [Abstract] [Full Text] [Related]
13. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved.
Shallis RM; Gale RP; Lazarus HM; Roberts KB; Xu ML; Seropian SE; Gore SD; Podoltsev NA
Blood Rev; 2021 May; 47():100773. PubMed ID: 33213985
[TBL] [Abstract] [Full Text] [Related]
14. Upregulation of circ-0000745 in acute lymphoblastic leukemia enhanced cell proliferation by activating erk pathway.
Liu X; Zhou C; Li Y; Deng Y; Lu W; Li J
Gene; 2020 Aug; 751():144726. PubMed ID: 32360844
[TBL] [Abstract] [Full Text] [Related]
15. Latest Advances in the diagnosis and Treatment of Large Granular Lymphocytic leukemia.
Moignet A; Lamy T
Am Soc Clin Oncol Educ Book; 2018 May; 38():616-625. PubMed ID: 30231346
[TBL] [Abstract] [Full Text] [Related]
16. Quantification of cancer risk in glomerulonephritis.
Heaf JG; Hansen A; Laier GH
BMC Nephrol; 2018 Feb; 19(1):27. PubMed ID: 29394927
[TBL] [Abstract] [Full Text] [Related]
17. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
Wever CM; Geoffrion D; Grande BM; Yu S; Alcaide M; Lemaire M; Riazalhosseini Y; Hébert J; Gavino C; Vinh DC; Petrogiannis-Haliotis T; Dmitrienko S; Mann KK; Morin RD; Johnson NA
Leuk Lymphoma; 2018 Sep; 59(9):2159-2174. PubMed ID: 29295643
[TBL] [Abstract] [Full Text] [Related]
18. Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.
Thiant S; Moutuou MM; Laflamme P; Sidi Boumedine R; Leboeuf DM; Busque L; Roy J; Guimond M
Blood Cancer J; 2017 Apr; 7(4):e551. PubMed ID: 28387753
[TBL] [Abstract] [Full Text] [Related]
19. Genomics of Hairy Cell leukemia.
Tiacci E; Pettirossi V; Schiavoni G; Falini B
J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
[TBL] [Abstract] [Full Text] [Related]
20. [FLT3 Mutations in Acute Myeloid leukemia].
Shoji T; Kida Y; Yamashita K; Ichiyama S
Rinsho Byori; 2017 Jan; 65(1):44-51. PubMed ID: 30695511
[TBL] [Abstract] [Full Text] [Related]
[Next]
